Affymax, Inc. (AFFY) Research

Affymax, Inc. presently lacks any substantial operational activities. In its earlier history, the firm concentrated on the creation of pharmaceutical agents designed to improve therapies for severe and frequently fatal health issues across the United States. Established in 2001, its corporate base is situated in New York, New York.

Market snapshot

Symbol
AFFY
Price
$0.00
Day change
0.00%
Market cap
$48.7K
P/E ratio
-0.00x
52-week range
0.0001-0.003
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Amarantus BioScience Holdings, Inc. (AMBS)
  • Baseline Productions, Inc. (BSSP)
  • CNBX Pharmaceuticals Inc. (CNBX)
  • Endonovo Therapeutics, Inc. (ENDV)
  • GeneLink, Inc. (GNLKQ)
  • Itoco Inc. (ITMC)
  • Naturally Splendid Enterprises Ltd. (NSPDF)
  • ONE Bio Corp. (ONBI)

Recent insider activity

  • WALKER JOHN PETER — S-Sale (16040 shares) on 2013-08-28
  • WALKER JOHN PETER — S-Sale (500 shares) on 2013-08-28
  • Orwin John A — F-InKind (16334 shares) on 2013-06-27
  • Orwin John A — G-Gift (15000 shares) on 2013-06-28
  • Knapp Jeffrey H — M-Exempt (1015 shares) on 2013-02-15

Open Affymax, Inc. (AFFY) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.